CVS Health fell short on third-quarter profit, but it posted strong sales and the health care giant shook up leadership under ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...

A vacant former CVS building in North Peoria is off the market. The property at 9315 N. Lindbergh Drive in Peoria was sold ...

CVS Health will report earnings on Wednesday morning, weeks after dumping its CEO in a desperate effort to reassure investors ...

CVS Health (NYSE:CVS) is scheduled to announce Q3 earnings results on Wednesday, November 6th, before market open. Analysts ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...